Bryan Chadwick Pridgen, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Residential Treatment | 2 | 2017 | 112 | 0.450 |
Why?
|
| Safety | 1 | 2010 | 1159 | 0.240 |
Why?
|
| User-Computer Interface | 1 | 2010 | 1407 | 0.220 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1397 | 0.210 |
Why?
|
| Internet | 1 | 2010 | 3110 | 0.140 |
Why?
|
| Play Therapy | 1 | 2013 | 17 | 0.110 |
Why?
|
| Receptors, Interleukin | 3 | 2000 | 243 | 0.110 |
Why?
|
| Self-Injurious Behavior | 2 | 2017 | 568 | 0.110 |
Why?
|
| Family Therapy | 1 | 2013 | 214 | 0.100 |
Why?
|
| Risperidone | 1 | 2013 | 383 | 0.090 |
Why?
|
| Citalopram | 1 | 2013 | 401 | 0.090 |
Why?
|
| Risk-Taking | 2 | 2016 | 1023 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 598 | 0.080 |
Why?
|
| Judgment | 1 | 2010 | 273 | 0.070 |
Why?
|
| Suicide, Attempted | 1 | 2016 | 1409 | 0.070 |
Why?
|
| Interleukin-8 | 3 | 2000 | 704 | 0.070 |
Why?
|
| Suicidal Ideation | 1 | 2016 | 1462 | 0.070 |
Why?
|
| Receptors, Chemokine | 2 | 2000 | 652 | 0.070 |
Why?
|
| Depressive Disorder | 1 | 2017 | 3721 | 0.060 |
Why?
|
| Antigens, CD | 3 | 2000 | 4035 | 0.060 |
Why?
|
| Interview, Psychological | 2 | 2017 | 810 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2017 | 3288 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2010 | 1186 | 0.050 |
Why?
|
| Social Support | 1 | 2010 | 2193 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2000 | 118 | 0.040 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 1999 | 93 | 0.040 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1999 | 283 | 0.040 |
Why?
|
| GTP-Binding Proteins | 2 | 1999 | 948 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 1999 | 280 | 0.040 |
Why?
|
| Psychotic Disorders | 1 | 2013 | 3276 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 1998 | 258 | 0.040 |
Why?
|
| Chemotaxis | 1 | 1999 | 600 | 0.030 |
Why?
|
| Case Management | 1 | 2017 | 277 | 0.030 |
Why?
|
| Receptors, Interleukin-8A | 3 | 2000 | 47 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2016 | 6029 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2017 | 994 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 1999 | 1418 | 0.030 |
Why?
|
| Education, Special | 1 | 2013 | 86 | 0.030 |
Why?
|
| Family Conflict | 1 | 2013 | 95 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1999 | 1247 | 0.020 |
Why?
|
| Child, Hospitalized | 1 | 2013 | 182 | 0.020 |
Why?
|
| Behavioral Symptoms | 1 | 2013 | 188 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2819 | 0.020 |
Why?
|
| Adolescent | 3 | 2017 | 89169 | 0.020 |
Why?
|
| Phospholipase C beta | 2 | 2000 | 49 | 0.020 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2000 | 58 | 0.020 |
Why?
|
| Family Health | 1 | 2013 | 1255 | 0.020 |
Why?
|
| Type C Phospholipases | 2 | 2000 | 287 | 0.020 |
Why?
|
| Phosphorylation | 4 | 2000 | 8317 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6229 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 2013 | 881 | 0.020 |
Why?
|
| Psychometrics | 1 | 2017 | 3063 | 0.020 |
Why?
|
| Neutrophils | 1 | 1998 | 3786 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8542 | 0.020 |
Why?
|
| Inpatients | 1 | 2016 | 2566 | 0.010 |
Why?
|
| Isoenzymes | 2 | 2000 | 1688 | 0.010 |
Why?
|
| Massachusetts | 1 | 2017 | 8890 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2013 | 1951 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12077 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 74944 | 0.010 |
Why?
|
| Disease Management | 1 | 2013 | 2536 | 0.010 |
Why?
|
| Cell Line | 3 | 2000 | 15597 | 0.010 |
Why?
|
| Receptors, CCR1 | 1 | 2000 | 30 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1999 | 154 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1999 | 176 | 0.010 |
Why?
|
| Receptors, Formyl Peptide | 1 | 1999 | 146 | 0.010 |
Why?
|
| Leukemia, Basophilic, Acute | 1 | 1998 | 15 | 0.010 |
Why?
|
| Rats | 3 | 2000 | 23760 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 826 | 0.010 |
Why?
|
| Leukotriene B4 | 1 | 1999 | 281 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1998 | 221 | 0.010 |
Why?
|
| Complement C5a | 1 | 1998 | 100 | 0.010 |
Why?
|
| Humans | 7 | 2017 | 768166 | 0.010 |
Why?
|
| Phospholipase D | 1 | 1998 | 70 | 0.010 |
Why?
|
| Exocytosis | 1 | 1999 | 323 | 0.010 |
Why?
|
| Signal Transduction | 2 | 1998 | 23645 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1998 | 280 | 0.010 |
Why?
|
| Depression | 1 | 2016 | 8230 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13671 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1998 | 660 | 0.010 |
Why?
|
| Endocytosis | 1 | 2000 | 956 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 24315 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 1998 | 525 | 0.010 |
Why?
|
| Hospitalization | 1 | 2013 | 10840 | 0.010 |
Why?
|
| Male | 3 | 2017 | 364719 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6124 | 0.010 |
Why?
|
| Kinetics | 1 | 1998 | 6329 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 5755 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 2885 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 6514 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 13421 | 0.000 |
Why?
|
| Female | 2 | 2017 | 397192 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 17622 | 0.000 |
Why?
|
| Calcium | 1 | 1998 | 5792 | 0.000 |
Why?
|
| Child | 1 | 2013 | 80917 | 0.000 |
Why?
|
| Animals | 3 | 2000 | 169246 | 0.000 |
Why?
|